FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34840711000001103: Hyoscine butylbromide 20mg/5ml oral suspension (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105553001000001114 Hyoscine butylbromide 20mg/5ml oral suspension (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105553101000001110 Hyoscine butylbromide 20mg/5ml oral suspension en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hyoscine butylbromide 20mg/5ml oral suspension Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspension.oral ontology form and route true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Has active ingredient Scopolamine true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Is a Hyoscine butylbromide false Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Has active ingredient Scopolamine butylbromide false Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Has specific active ingredient Scopolamine butylbromide true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Is a Hyoscine butylbromide true Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Hyoscine butylbromide 20mg/5ml oral suspension (Special Order) Is a True Hyoscine butylbromide 20mg/5ml oral suspension Inferred relationship Existential restriction modifier
Hyoscine butylbromide 20mg/5ml oral suspension 1 ml Has VMP True Hyoscine butylbromide 20mg/5ml oral suspension Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start